Chemical Structure (Colistimethate For Injection Usp 1)
Colistimethate Injection, Powder, For Solution
Product Images NDC 0143-9443
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Colistimethate (NDC 0143-9443). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Colistimethate For Injection Usp 2)
This text appears to provide information regarding colistin base activity measurement in urine and serum after the parenteral administration of Colistimethate for Injection in adults. The measurement unit mentioned is meg/mL and the values seem to be documented in Figure 1.*
Vial Label (Colistimethate For Injection Usp 3)
This text provides information about a colistimethate sodium injection containing 150mg of colistin base activity. It includes details such as storage instructions, manufacturer information (Hikma Pharmaceuticals), and the NDC number. The medication is indicated for intramuscular and intravenous use. For complete prescribing information and reconstitution directions, refer to the package insert.*
Carton (Colistimethate For Injection Usp 4)
This text appears to be a package insert for a medication in vial form. The medication is colistimethate sodium USP equivalent to 150 mg colistin base activity per vial. The instructions mention reconstitution and storage conditions between 20° to 25°C. It provides details on the usual dose, how to store reconstituted solution, expiration date, and usage information for both intramuscular and intravenous routes. The medication is manufactured by Hikma Pharmaceuticals USA, Inc.*
Carton 12 (Colistimethate For Injection Usp 5)
This is a description of colistimethate sodium injection, USP containing 150 mg of colistin base activity per vial. It provides information on storage conditions, dosage guidelines, and reconstitution instructions. The medication is intended for intramuscular and intravenous use in patients with infections, with recommended dosages tailored to renal function and infection severity. The text also includes the manufacturer's details and NDC numbers for identification.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
